Cargando…

Dermal Drug Delivery of Phytochemicals with Phenolic Structure via Lipid-Based Nanotechnologies

Phenolic compounds are a large, heterogeneous group of secondary metabolites found in various plants and herbal substances. From the perspective of dermatology, the most important benefits for human health are their pharmacological effects on oxidation processes, inflammation, vascular pathology, im...

Descripción completa

Detalles Bibliográficos
Autores principales: Gugleva, Viliana, Ivanova, Nadezhda, Sotirova, Yoana, Andonova, Velichka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8471500/
https://www.ncbi.nlm.nih.gov/pubmed/34577536
http://dx.doi.org/10.3390/ph14090837
_version_ 1784574482900320256
author Gugleva, Viliana
Ivanova, Nadezhda
Sotirova, Yoana
Andonova, Velichka
author_facet Gugleva, Viliana
Ivanova, Nadezhda
Sotirova, Yoana
Andonova, Velichka
author_sort Gugleva, Viliana
collection PubMed
description Phenolic compounds are a large, heterogeneous group of secondary metabolites found in various plants and herbal substances. From the perspective of dermatology, the most important benefits for human health are their pharmacological effects on oxidation processes, inflammation, vascular pathology, immune response, precancerous and oncological lesions or formations, and microbial growth. Because the nature of phenolic compounds is designed to fit the phytochemical needs of plants and not the biopharmaceutical requirements for a specific route of delivery (dermal or other), their utilization in cutaneous formulations sets challenges to drug development. These are encountered often due to insufficient water solubility, high molecular weight and low permeation and/or high reactivity (inherent for the set of representatives) and subsequent chemical/photochemical instability and ionizability. The inclusion of phenolic phytochemicals in lipid-based nanocarriers (such as nanoemulsions, liposomes and solid lipid nanoparticles) is so far recognized as a strategic physico-chemical approach to improve their in situ stability and introduction to the skin barriers, with a view to enhance bioavailability and therapeutic potency. This current review is focused on recent advances and achievements in this area.
format Online
Article
Text
id pubmed-8471500
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-84715002021-09-28 Dermal Drug Delivery of Phytochemicals with Phenolic Structure via Lipid-Based Nanotechnologies Gugleva, Viliana Ivanova, Nadezhda Sotirova, Yoana Andonova, Velichka Pharmaceuticals (Basel) Review Phenolic compounds are a large, heterogeneous group of secondary metabolites found in various plants and herbal substances. From the perspective of dermatology, the most important benefits for human health are their pharmacological effects on oxidation processes, inflammation, vascular pathology, immune response, precancerous and oncological lesions or formations, and microbial growth. Because the nature of phenolic compounds is designed to fit the phytochemical needs of plants and not the biopharmaceutical requirements for a specific route of delivery (dermal or other), their utilization in cutaneous formulations sets challenges to drug development. These are encountered often due to insufficient water solubility, high molecular weight and low permeation and/or high reactivity (inherent for the set of representatives) and subsequent chemical/photochemical instability and ionizability. The inclusion of phenolic phytochemicals in lipid-based nanocarriers (such as nanoemulsions, liposomes and solid lipid nanoparticles) is so far recognized as a strategic physico-chemical approach to improve their in situ stability and introduction to the skin barriers, with a view to enhance bioavailability and therapeutic potency. This current review is focused on recent advances and achievements in this area. MDPI 2021-08-24 /pmc/articles/PMC8471500/ /pubmed/34577536 http://dx.doi.org/10.3390/ph14090837 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Gugleva, Viliana
Ivanova, Nadezhda
Sotirova, Yoana
Andonova, Velichka
Dermal Drug Delivery of Phytochemicals with Phenolic Structure via Lipid-Based Nanotechnologies
title Dermal Drug Delivery of Phytochemicals with Phenolic Structure via Lipid-Based Nanotechnologies
title_full Dermal Drug Delivery of Phytochemicals with Phenolic Structure via Lipid-Based Nanotechnologies
title_fullStr Dermal Drug Delivery of Phytochemicals with Phenolic Structure via Lipid-Based Nanotechnologies
title_full_unstemmed Dermal Drug Delivery of Phytochemicals with Phenolic Structure via Lipid-Based Nanotechnologies
title_short Dermal Drug Delivery of Phytochemicals with Phenolic Structure via Lipid-Based Nanotechnologies
title_sort dermal drug delivery of phytochemicals with phenolic structure via lipid-based nanotechnologies
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8471500/
https://www.ncbi.nlm.nih.gov/pubmed/34577536
http://dx.doi.org/10.3390/ph14090837
work_keys_str_mv AT guglevaviliana dermaldrugdeliveryofphytochemicalswithphenolicstructurevialipidbasednanotechnologies
AT ivanovanadezhda dermaldrugdeliveryofphytochemicalswithphenolicstructurevialipidbasednanotechnologies
AT sotirovayoana dermaldrugdeliveryofphytochemicalswithphenolicstructurevialipidbasednanotechnologies
AT andonovavelichka dermaldrugdeliveryofphytochemicalswithphenolicstructurevialipidbasednanotechnologies